Stay updated on REGN668 Safety in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the REGN668 Safety in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the REGN668 Safety in Atopic Dermatitis Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    No significant changes detected; any differences are minor UI adjustments that do not affect core study information such as eligibility, study design, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T00:45:09.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    Core content updated to include a government funding lapse notice and operating-status guidance; version updated to v3.2.0.
    Difference
    5%
    Check dated 2025-10-05T04:54:08.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.1%
    Check dated 2025-09-28T02:47:41.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed; no substantive changes to pricing or core content.
    Difference
    0.3%
    Check dated 2025-09-13T16:48:50.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.3%
    Check dated 2025-09-06T14:21:30.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The web page has added significant information regarding a facility and drug availability, specifically for Dupilumab and its relevance to skin and connective tissue diseases. However, it has removed a substantial amount of related medical topics and location details.
    Difference
    4%
    Check dated 2025-08-30T11:10:46.000Z thumbnail image

Stay in the know with updates to REGN668 Safety in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the REGN668 Safety in Atopic Dermatitis Clinical Trial page.